The TREM2 R47H variant is associated with an approximately 3-fold increased risk for AD, while the APOE E4 variant is associated with a ~3- to 4-fold increased risk with one copy and ~10- to 12-fold increased risk with two copies [8, 11, 12]. This evidence concerns the gene APOE and Alzheimer disease.